We have well qualified scientists on the clinical side of things and the scientific advisory board. We have a few members of the management team as well as the Board of Directors that are experienced and knowledgeable, some with great science credentials.
Where we are falling short is the administrative side where dealing with regulatory agencies, partners and shareholders is important. The professionalism of key members of the team running daily operations is lacking.
(7)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links